Who are Coenzyme Q10's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Methylene blue (1%), Tafenoquine prophylaxis, Atovaquone / Proguanil, Coenzyme Q10 (drug), Training+Simvastatin+Q10, Atovaquone Proguanil and Artesunate Pyronaridine.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/coenzyme-q10.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Coenzyme Q10 — Competitive Intelligence Brief

Coenzyme Q10 (Coenzyme Q10) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Dietary supplement. Area: Neuroscience.

marketed Dietary supplement Mitochondrial electron transport chain Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Coenzyme Q10 (Coenzyme Q10) — Nanjing Medical University.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Coenzyme Q10 TARGET	Coenzyme Q10	Nanjing Medical University	marketed	Dietary supplement	Mitochondrial electron transport chain
Methylene blue (1%)	Methylene blue (1%)	University Hospital, Strasbourg, France	marketed	Redox agent; monoamine oxidase inhibitor	Mitochondrial electron transport chain; monoamine oxidase; methemoglobin reductase
Tafenoquine prophylaxis	Tafenoquine prophylaxis	Naval Medical Research Center	marketed	8-aminoquinoline antimalarial	Plasmodium mitochondrial electron transport chain
Atovaquone / Proguanil	Atovaquone / Proguanil	Radboud University Medical Center	marketed	Antimalarial combination	Mitochondrial electron transport chain (atovaquone); dihydrofolate reductase (proguanil)
Coenzyme Q10 (drug)	Coenzyme Q10 (drug)	University of Shizuoka	marketed	Mitochondrial cofactor / Antioxidant	Mitochondrial electron transport chain (Complexes I-III, Complex IV)
Training+Simvastatin+Q10	Training+Simvastatin+Q10	University of Copenhagen	marketed	Combination therapy (statin + supplement + lifestyle intervention)	HMG-CoA reductase (simvastatin); mitochondrial electron transport chain (CoQ10)
Atovaquone Proguanil and Artesunate Pyronaridine	Atovaquone Proguanil and Artesunate Pyronaridine	Armed Forces Research Institute of Medical Sciences, Thailand	marketed	Antimalarial combination	Plasmodium mitochondrial electron transport chain, dihydrofolate reductase, heme polymerase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Dietary supplement class)

Inje University · 1 drug in this class
McMaster University · 1 drug in this class
Nanjing Medical University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Coenzyme Q10 — Competitive Intelligence Brief. https://druglandscape.com/ci/coenzyme-q10. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab